Armistice Capital Master Fund Ltd., 10% Owner at Avalo Therapeutics, Inc. (AVTX), sold 7,367,084 shares at $0.52 ($4.3M) on 2023-06-27, disclosed to the SEC on 2023-06-28.
Open-market sale of $4.3M AVTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.61 | 2,746,138 | $1.7M | 38.7% |
| 2 | $0.61 | 2,746,138 | $1.7M | 38.7% |
| 3 | $0.52 | 937,404 | $487K | 11.3% |
| 4 | $0.52 | 937,404 | $487K | 11.3% |
| Total | $0.59 avg | 7,367,084 | $4.3M | 100% |
| Filing → |
| AYTU | BUY | 2020-12-15 | $8.0M | — | Filing → |
| CERC | BUY | 2020-12-07 | $49K | — | Filing → |
| RSLS | BUY | 2020-11-12 | $9K | — | Filing → |